Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein

[Image: see text] The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 28,000,000 infections and 900,000 deaths worldwide to date. Antibody development efforts mainly revolve around the extensively glycosylated SARS-CoV-2 spik...

Descripción completa

Detalles Bibliográficos
Autores principales: Casalino, Lorenzo, Gaieb, Zied, Goldsmith, Jory A., Hjorth, Christy K., Dommer, Abigail C., Harbison, Aoife M., Fogarty, Carl A., Barros, Emilia P., Taylor, Bryn C., McLellan, Jason S., Fadda, Elisa, Amaro, Rommie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523240/
https://www.ncbi.nlm.nih.gov/pubmed/33140034
http://dx.doi.org/10.1021/acscentsci.0c01056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523240/
https://www.ncbi.nlm.nih.gov/pubmed/33140034
http://dx.doi.org/10.1021/acscentsci.0c01056

Ejemplares similares